News

This week, a strategic approach along with existing treatments aimed at reducing incidence rates and curing people of HCV, advocating Lyme disease research in honor of May being its awareness month, Digestive Disease Week coverage, and more this week from Contagion.

With 9 confirmed cases, recent incidences in schools and in the community, caregivers and individuals should stay informed if symptoms appear.

Recent study examines the relationship between COVID-19 vaccination and post-COVID conditions, shedding light on the potential long-term effects of vaccination.

Study results on Vowst were presented at the recent DDW conference.

February through April 2024 Chicago faced a measles outbreak within a migrant shelter, prompting action from the CDC.

A Michigan farmworker who had regular contact with livestock was confirmed to have contracted the virus.

A newer strategic approach combined with existing treatments are together trying to reduce incidence rates and cure people of HCV, but barriers to treatment remain, and often leave people outside the continuum of care.

This report underscores the increase of STIs alongside the ongoing global epidemics of HIV and viral hepatitis in the Americas and African regions.

Authorized for children in malaria-endemic regions, this vaccine aims to bridge the gap between demand and supply, offering hope against malaria's toll.

During Lyme Disease Awareness Month, advocating for collective action in research, education, and prevention can help tackle the challenges of Lyme disease and promote healthier communities nationwide.

The novel vaccine, ARCT-154, is a self-amplifying messenger RNA (sa-mRNA) vaccine and now has the first published demonstration of clinical efficacy for this type of vaccine.

At Digestive Disease Week, Paul Feuerstadt MD, FACG, AGAF and fellow investigators explore the potential impact of non-antibiotic medications on gut health and their association with recurrent CDI.

Both the World Health Organization and FDA have now recommended this particular set of viruses be left off influenza vaccines for the 2024-2025 respiratory virus season. A new study points to further evidence of their extinction.

Recent study sheds light on potential mechanisms underlying severe lung damage in COVID-19 patients.

A study shows the definitive presence of the virus long-term in individuals and could point to lingering symptoms and the possibility of Long COVID.

Regarding new-onset seizures in the general population, there was not a statistically significant variance in the risk of experiencing seizures between those who received the vaccine and those who got a placebo.

The program allows participants to reserve doses and be eligible for priority shipping, among other benefits.

Efforts among organizations aim to develop innovative vaccine candidates and advancements in the global fight against HIV.

Importance of thorough travel history assessment, consistent surveillance, and outreach efforts to manage malaria morbidity among travelers in the US.

This week, irrigation water in Utah creates E coli outbreak, FDA issues CRL for HEPLISAV-B 4 dose regimen, living with C diff awareness, and more this week from Contagion.

Hepatitis awareness remains essential to promote prevention and early detection, ensuring access to vaccination and treatment, and improving public health.

A new study demonstrates that for last year’s respiratory season, the difference in death rates were still much higher for COVID-19, but the gap closed significantly from the year before.

North Carolina’s senate voted to repeal the health exemption of the existing mask wearing law, thus disallowing any exceptions for people to wear a mask across the state.

Insights from virologist Erin Sorrell PhD MSc offer perspectives on prevention and response strategies.

Research indicates serum LOXL2 levels could serve as a predictor for hepatocellular carcinoma (HCC) risk in HCV patients who have achieved sustained virological response (SVR).

Insights from research on bloodstream infections with key attributions from study researcher Arden Baylink PhD.

Dennis Petragnani has battled gastrointestinal issues for years, and he shares what he sees as the transformation of change in the public and medical community talking about C diff and therapies around it, and the kinship with people he has met through the Peggy Lillis Foundation.

A large study on the future directions unveiling COVID-19 vaccine safety and risks.